Company expects to commence Phase 3 trial of Descartes-08 in patients with myasthenia gravis in 1H2025 following recent meeting with U.S. Food ...

AI has shown promise by analysing data from patient records to recognise complex patterns within large datasets, which can aid in the ...

This information could help your doctor choose the right treatment. Chest X-ray. This can show whether your lungs are damaged, a possible sign of dermatomyositis. Electromyography.This test looks ...

Priovant expects to have results from its Phase 3 dermatomyositis study in the ... the same group of people who would be prescribing the treatment to patients. "With rare disease ...

Patients often get better with treatment. But while taking these medications, it's important to be careful to avoid getting infections. Dermatomyositis is a rare autoimmune illness where the body ...

To evaluate the influence of environmental factors and prematurity relating to juvenile dermatomyositis (JDM), its course and refractoriness to treatment. Maternal exposure to occupational pollutants ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...

A diagnosis of anti-MDA5 amyopathic dermatomyositis was made. Treatment with a combination of oral prednisolone (30 mg per day for 2 weeks, tapered over 2 months), mycophenolate mofetil (2 g per day), ...

Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on CRBP stock, giving a Buy rating yesterday. Graig ...

The findings, published in Immunity, could lead to new treatments targeting IL-1β ... or patients with the autoimmune disease juvenile dermatomyositis. Mitochondria are normally degraded during ...